Dr. Peter Choyke Discusses Molecular Imaging Research

Peter L. Choyke, MD
Published: Thursday, Sep 06, 2012

Peter L. Choyke, MD, head, Imaging Section, program director, Molecular Imaging Program, National Cancer Institute, explains that the goal of molecular imaging research is to find imaging probes that match up with targeted therapies, which can be very diverse and occupy many different pathways in cancer.

A clear need exists for new molecular imaging probes that are able to select patients who are most appropriate for highly targeted cancer treatments. Additionally, probes are needed that can be used to monitor and detect when a patient responds. Optimal outcomes can be achieved by predicting the efficacy of treatment before progression or resistance occurs.

Choyke explains that research into new imaging probes and tests for the rapidly expanding field of targeted therapies is currently underway at the NCI Molecular Imaging Program.

Peter L. Choyke, MD, head, Imaging Section, program director, Molecular Imaging Program, National Cancer Institute, explains that the goal of molecular imaging research is to find imaging probes that match up with targeted therapies, which can be very diverse and occupy many different pathways in cancer.

A clear need exists for new molecular imaging probes that are able to select patients who are most appropriate for highly targeted cancer treatments. Additionally, probes are needed that can be used to monitor and detect when a patient responds. Optimal outcomes can be achieved by predicting the efficacy of treatment before progression or resistance occurs.

Choyke explains that research into new imaging probes and tests for the rapidly expanding field of targeted therapies is currently underway at the NCI Molecular Imaging Program.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x